Learn More
Medchemexpress LLC 6-[2-(2,4-difluorophenoxy)-5-(ethylsulfonylmethyl)-3-pyridinyl]-8-methyl-2H-pyrrolo[1,2-a]pyrazin-1-on | 2411226-02-1 | 99.9% | 459.47 g·mol⁻¹ | C22H19F2N3O4S | 5 MG

Supplier: Medchemexpress LLC HY1310615MG
BET bromodomain inhibitor 1 is a selective, orally active inhibitor of bromodomain and extra-terminal (BET) proteins with potent activity against BRD4 (IC50 = 2.6 nM). Supplied as a white to off-white solid with high purity, it is used in epigenetic target validation and anticancer mechanism research.
- Potent BRD4 inhibition (IC50 2.6 nM).
- Low-nanomolar binding to BET family bromodomains.
- High purity suitable for research (99.9%).
- Soluble in DMSO at 100 mg/mL with warming and sonication.
- Stable when stored as a powder at -20°C for long-term storage.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.